Vertex-Crinetics Pharmaceuticals deal faces Australian review
MLex Summary: Vertex Pharmaceuticals’ proposal to acquire Crinetics Pharmaceuticals will be reviewed by Australia’s antitrust watchdog. In a statement on Wednesday, the Australian Competition & Consumer Commission said that Vertex, a...To view the full article, register now.
Already a subscriber? Click here to view full article